<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04725695</url>
  </required_header>
  <id_info>
    <org_study_id>2020-005177-27</org_study_id>
    <nct_id>NCT04725695</nct_id>
  </id_info>
  <brief_title>Preoperative Viscous Lidocaine for Upper Gastrointestinal Endoscopy</brief_title>
  <acronym>LIDOGAS</acronym>
  <official_title>Preoperative Viscous Lidocaine for Upper Gastrointestinal Endoscopy - a Blinded, Randomized, Placebo-controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this randomized placebo-controlled clinical trial, patients will be randomized to be&#xD;
      administered viscous lidocaine or placebo preoperatively to elective upper endoscopy&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ease of intubation</measure>
    <time_frame>Immediately after the procedure</time_frame>
    <description>The endoscopist will rate the difficulty of intubating the esophagus on a numeric rating scale (NRS) from 0 (worst) to 10 (best)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ease of examination</measure>
    <time_frame>Immediately after the procedure</time_frame>
    <description>The endoscopist will rate the difficulty of performing the endoscopy on a numeric rating scale (NRS) from 0 (worst) to 10 (best)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of intubation attempts</measure>
    <time_frame>Peroperatively counted by the assisting nurse</time_frame>
    <description>Total number of intubation attempts until the esophagus is reached</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of gag reflexes</measure>
    <time_frame>Peroperatively counted by the assisting nurse</time_frame>
    <description>Total number of gag reflexes during the examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's perception of discomfort</measure>
    <time_frame>Immediately after the procedure</time_frame>
    <description>The patient's self-evaluation of discomfort during the examination on a numeric rating scale (NRS) from 0 (worst) to 10 (best)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's willingness to be reexamined</measure>
    <time_frame>Immediately after the procedure</time_frame>
    <description>The patient's willingness to have the procedure performed again in the future on a numeric rating scale (NRS) from 0 (worst) to 10 (best)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation 1</measure>
    <time_frame>Peroperatively</time_frame>
    <description>Number of milligrams midazolam administered during the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation 2</measure>
    <time_frame>Peroperatively</time_frame>
    <description>Number of milligrams alfentanil administered during the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perception of gag reflexes</measure>
    <time_frame>Immediately after the procedure</time_frame>
    <description>The endoscopist's rating of the patient's degree of gag reflexes, numeric rating scale (NRS) from 0 (worst) to 10 (best)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">248</enrollment>
  <condition>Anesthetics, Local</condition>
  <condition>Esophagogastroduodenoscopy</condition>
  <arm_group>
    <arm_group_label>Viscous lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral viscous lidocaine 20 mg/ml, 10 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Oral viscous solution without active drug, 10 ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Viscous Lidocaine</intervention_name>
    <description>The patients will be randomized to either viscous lidocaine or placebo</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Viscous lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients referred to and found fit for upper GI endoscopy in an out patient setting&#xD;
&#xD;
          -  Between 18 and 75 years old&#xD;
&#xD;
          -  Speaks and understands Danish&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients admitted for upper GI endoscopy in an in-patient setting&#xD;
&#xD;
          -  Patients with dementia and/or other cognitive dysfunction disorders&#xD;
&#xD;
          -  Patients primarily complaining of dysphagia&#xD;
&#xD;
          -  Patients allergic to lidocaine&#xD;
&#xD;
          -  Patients with suspected retention&#xD;
&#xD;
          -  Patients who will undergo upper GI endoscopy with nurse-assisted propofol sedation&#xD;
&#xD;
          -  Patients who will undergo upper GI endoscopy with assistance of anesthesia-personnel&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erling Oma, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Digestive Disease Center, Bispebjerg Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erling Oma, MD, PhD</last_name>
    <phone>004527526724</phone>
    <email>erling.oma@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Endoscopy, Digestive Disease Center, Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <contact>
      <last_name>Erling Oma, MD, PhD</last_name>
      <phone>004527526724</phone>
      <email>erling.oma@regionh.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2021</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Erling Oma</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>After publication for 10 years</ipd_time_frame>
    <ipd_access_criteria>On demand</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

